Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ · Healthcare
Vertex Pharmaceuticals Incorporated Shareholder Equity 2008–2025
Vertex Pharmaceuticals Incorporated annual shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Vertex Pharmaceuticals Incorporated shareholder equity as of December 31, 2025: 18.67B, a 13.75% increase year-over-year.
- Vertex Pharmaceuticals Incorporated shareholder equity for 2025 were 18.67B, a 13.75% increase from 2024.
- Vertex Pharmaceuticals Incorporated shareholder equity for 2024 were 16.41B, a 6.66% decrease from 2023.
- Vertex Pharmaceuticals Incorporated shareholder equity for 2023 were 17.58B, a 26.36% increase from 2022.
- Vertex Pharmaceuticals Incorporated shareholder equity for 2022 were 13.91B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Vertex Pharmaceuticals Incorporated Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $18,666 |
| 2024 | $16,410 |
| 2023 | $17,580 |
| 2022 | $13,913 |
| 2021 | $10,100 |
| 2020 | $8,687 |
| 2019 | $6,085 |
| 2018 | $4,435 |
| 2017 | $2,029 |
| 2016 | $1,157 |
| 2015 | $940 |
| 2014 | $1,075 |
| 2013 | $1,356 |
| 2012 | $999 |
| 2011 | $787 |
Vertex Pharmaceuticals Inc. Shareholder Equity — FAQ
Vertex Pharmaceuticals Inc. (VRTX) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRTX's shareholder equity history?
The chart and table above show Vertex Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.